Results 101 to 110 of about 30,247,731 (144)

Loss of the Mechanistic Target of Rapamycin Complex 1 Causes a Lethal Alpha-1 Antitrypsin Deficiency-Associated Liver Disease. [PDF]

Cell Mol Gastroenterol Hepatol
Bewersdorf L, Haber S, Volkert I, Remih K, Gross A, Preisinger C, Kroll L, Cramer T, Gaisa NT, Leypold S, Rolle-Kampczyk U, Brunetti-Pierri N, von Bergen M, Rosenberger F, Weiss C, Guldiken N, Strnad P.   +16 more
europepmc   +1 more source

Association between alpha 1-antitrypsin levels and intracranial aneurysms: a case-control study. [PDF]

Arq Neuropsiquiatr
Rosi Júnior J, Telles JPM, Santana LS, Bassan JL, Giraldo JP, Rabelo NN, Figueiredo EG.   +6 more
europepmc   +1 more source

Circulating alpha-1 antitrypsin and its c-terminal peptides differentiate bacterial from viral community-acquired pneumonia. [PDF]

J Transl Med
Pashai Fakhri M, Börner FR, Held J, Sivaraman K, Fuge J, Rupp J, Barten-Neiner G, Pletz MW, Witzenrath M, Rohde G, Rademacher J, Hinze CA, Janciauskiene S, CAPNETZ Study Group.   +13 more
europepmc   +1 more source

Decalogue of Best Practices in Alpha-1 Antitrypsin Deficiency. [PDF]

Open Respir Arch
Hernández-Pérez JM, Dasí F, Miravitlles M, Diab-Cáceres L, Casas-Maldonado F, Martínez-Delgado B, Esquinas-López C, Moya-Álvarez V, Calle M, Michel-de La Rosa FJ, Callejas-González FJ, Rodríguez-García C, Barrecheguren M, Parra-Parra I, Torres-Durán M, Curi-Chércoles S, Lázaro-Asegurado L, Bustamante A, Castillo-Corullón S, López-Campos JL.   +19 more
europepmc   +1 more source

Z variant heterozygosity in alpha-1 antitrypsin deficiency: disease risk and treatment implications. [PDF]

Orphanet J Rare Dis
Hersh CP, Teckman JH, Strnad P, Hakim A, Carroll TP, Hall IP, Ghosh AJ, Barjaktarevic I, McElvaney NG, Kaserman JE, Lomas DA, Strange C, Drummond MB, Rennard S, Hanna KE, Clark VC, Goldklang MP, Iverson P, Wilson AA.   +18 more
europepmc   +1 more source

RNA editing for the treatment of alpha-1 antitrypsin deficiency. [PDF]

Nucleic Acids Res
Monian P, Shivalila C, Lu G, Bowman K, Briem S, Bylsma M, Byrne M, Cannon M, Chatterjee A, Dallaire M, Desai J, Dufresne J, Faraone A, Favaloro F, Friend S, Ghosh A, Godfrey J, Hernandez N, Huth O, Iwamoto N, Kawamoto T, Lamattina A, Lemaitre M, Lindsey A, Liu F, Looby R, Luu K, McGlynn A, Metterville J, Paik IH, Pan Q, Patil S, Pu T, Purcell-Estabrook E, Ranade A, Rheinhardt J, Rossi J, Shimizu M, Singh K, Standley S, Thomas C, Tripathi S, Yang H, Yordanoff R, Yin Y, Yu H, Narayanan P, Kandasamy P, Giangrande PH, Vargeese C.   +49 more
europepmc   +1 more source

Retraction: The Irish National Alpha-1 Antitrypsin Deficiency (AATD) Registry: Examining the Prevalence of Radiological Abnormalities in a Population With Severe AATD. [PDF]

Cureus
Nameera A.
europepmc   +1 more source

Functional and clinical significance of novel SERPINA1 variants on alpha-1 antitrypsin deficiency. [PDF]

Respir Res
Matamala N, Osaba L, Drobnic E, Gil-Martín S, Martín-Galiano AJ, Almadana-Pacheco V, Cazorla MJ, Costa F, Souza-Sokoloski C, Çörtük M, Serra-Fortuny M, Ortiz-de Saracho J, Lloret-Queraltó JA, Rodriguez-Lázaro N, Michel-de la Rosa FJ, Rodríguez-Hermosa JL, Saldaña-Pérez L, Akıncı E, Alonso J, Benítez-Buelga C, Gómez-Mariano G, López-Campos JL, Martínez-Delgado B.   +22 more
europepmc   +1 more source

Delineating a reference interval for functional alpha-1 antitrypsin in the serum of healthy Pi*MM donors using an anti-neutrophil elastase capacity assay. [PDF]

Respir Res
Merdek KD, Draganov D, Kim Y, Sargentini-Maier ML, Thibault N, Kalabus J, Ramani V, Veldstra C, Lee M.   +8 more
europepmc   +1 more source